ARVN Arvinas Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARVN

Price (delayed)

$63.63

Market cap

$3.12B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.29

Enterprise value

$2.78B

Sector: Healthcare
Industry: Biotechnology

Highlights

The quick ratio has surged by 102% year-on-year and by 15% since the previous quarter
The company's equity has surged by 191% YoY but it fell by 4.2% QoQ
The company's net income has shrunk by 78% YoY and by 16% QoQ
The debt has surged by 71% since the previous quarter and by 46% year-on-year

Key stats

What are the main financial stats of ARVN
Market
Shares outstanding
48.99M
Market cap
$3.12B
Enterprise value
$2.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.05
Price to sales (P/S)
146.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
131.65
Earnings
Revenue
$21.1M
EBIT
-$138.49M
EBITDA
-$133.8M
Free cash flow
-$117.85M
Per share
EPS
-$3.29
Free cash flow per share
-$2.42
Book value per share
$12.59
Revenue per share
$0.43
TBVPS
$14.02
Balance sheet
Total assets
$681.77M
Total liabilities
$66.47M
Debt
$6.92M
Equity
$615.3M
Working capital
$624.28M
Liquidity
Debt to equity
0.01
Current ratio
16.46
Quick ratio
16.26
Net debt/EBITDA
2.53
Margins
EBITDA margin
-634.1%
Gross margin
100%
Net margin
-656.6%
Operating margin
-678.1%
Efficiency
Return on assets
-28.7%
Return on equity
-33.4%
Return on invested capital
-74.3%
Return on capital employed
-21.6%
Return on sales
-656.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARVN stock price

How has the Arvinas stock price performed over time
Intraday
0.76%
1 week
-7.7%
1 month
-1.13%
1 year
16.47%
YTD
-25.08%
QTD
-3.74%

Financial performance

How have Arvinas's revenue and profit performed over time
Revenue
$21.1M
Gross profit
$21.1M
Operating income
-$143.09M
Net income
-$138.56M
Gross margin
100%
Net margin
-656.6%
ARVN's operating income has plunged by 142% YoY and by 15% from the previous quarter
The company's net income has shrunk by 78% YoY and by 16% QoQ
Arvinas's revenue has plunged by 53% YoY and by 3.2% from the previous quarter
The gross profit has plunged by 53% YoY and by 3.2% from the previous quarter

Growth

What is Arvinas's growth rate over time

Valuation

What is Arvinas stock price valuation
P/E
N/A
P/B
5.05
P/S
146.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
131.65
The EPS has contracted by 47% YoY and by 9% from the previous quarter
The company's equity has surged by 191% YoY but it fell by 4.2% QoQ
The stock's price to book (P/B) is 6% less than its last 4 quarters average of 5.4
The P/S is 58% above the last 4 quarters average of 92.9
Arvinas's revenue has plunged by 53% YoY and by 3.2% from the previous quarter

Efficiency

How efficient is Arvinas business performance
The company's return on invested capital has shrunk by 91% YoY and by 3.1% QoQ
ARVN's return on equity is up by 26% year-on-year and by 12% since the previous quarter
The ROS has contracted by 20% from the previous quarter
ARVN's return on assets is up by 11% year-on-year and by 8% since the previous quarter

Dividends

What is ARVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARVN.

Financial health

How did Arvinas financials performed over time
ARVN's total assets has soared by 141% YoY but it is down by 5% from the previous quarter
ARVN's current ratio has soared by 102% YoY and by 15% QoQ
The debt is 99% smaller than the equity
The company's equity has surged by 191% YoY but it fell by 4.2% QoQ
The debt has surged by 71% since the previous quarter and by 46% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.